Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Now pushed down to a $25M market cap with only 30M shares outstanding, with the company on the verge of attaining net profitability this fiscal Q3 or next...and projected 2018 FocalinXR revenues of at least $5M and Mackie analyst projecting 2018 SeroquelXR revenues of $20M.

To say that these historic depressed share price levels are absolutely ludicrous is putting it mildly.

There's no logic whatsoever to be trading at a $25M market cap when 1 factors in the current quarter over quarter and YOY revenue growth now underway.

All we can do is wait for the temporary market insanity to pass glty